DOR BioPharma Partners With Sigma-Tau Pharmaceuticals
February 13, 2009 (FinancialWire) -- DOR BioPharma, Inc. (OTCBB: DORB) (Current Market Cap: US$14.76 Bil.) said that it has signed a potential $30 million partnering agreement with Sigma-Tau Pharmaceuticals, Inc. for the development and …